Breaking News Instant updates and real-time market news.

AMRS

Amyris

$4.09

-0.15 (-3.54%)

17:01
05/20/19
05/20
17:01
05/20/19
17:01

Amyris receives Nasdaq deficiency notification over delayed quarterly report

Amyris, Inc. reported that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended March 31, 2019, and because it remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2018, it is not in compliance with Nasdaq Listing Rule 5250c1, which requires timely filing of periodic financing reports with the Securities and Exchange Commission. The Nasdaq notice has no immediate effect on the listing or trading of Amyris's common stock on the Nasdaq Global Select Market. Under Nasdaq's listing rules, Amyris has until June 3, 2019 to submit a plan to regain compliance and the company does not believe it will have filed its 2018 Form 10-K or Form 10-Q for the quarter ended March 31, 2019 by this date. If the plan is accepted by Nasdaq, Amyris can be granted an exception of up to 180 calendar days from the original due date of the 2018 Form 10-K which the company has not filed yet, or until September 30, 2019, to regain compliance. Amyris is working diligently to complete and file its 2018 Form 10-K and Form 10-Q for the quarter ended March 31, 2019 and, assuming its plan is accepted by Nasdaq, expects to regain compliance within the timeline prescribed by Nasdaq. The company recently engaged a new auditor to facilitate meeting its filing compliance.

AMRS Amyris
$4.09

-0.15 (-3.54%)

11/14/18
HCWC
11/14/18
NO CHANGE
Target $11
HCWC
Buy
Amyris price target lowered to $11 from $15 at H.C. Wainwright
H.C. Wainwright analyst Amit Dayal lowered his price target for Amyris to $11 to reflect a more conservative stance on forward projections, including removing around $40M of anticipated annual Vitamin E royalty revenues, following the company's revenue miss in Q3. The analyst, however, keeps a Buy rating on the shares.
12/07/18
HCWC
12/07/18
NO CHANGE
HCWC
Amyris financing removes 'important overhang,' says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal reiterated a Buy rating and $11 price target on Amyris, noting that the company announced it has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes, in a private placement with two investors. Dayal said this financing removes an "important overhang" for the company, and believes that Amyris is now positioned to focus on execution during 2019. The analyst added that he is looking forward to more information from the company during the last three weeks of this year, including the announcement of a Chinese licensing agreement.
12/31/18
HCWC
12/31/18
NO CHANGE
Target $11
HCWC
Buy
Amyris news today a 'significant near-term milestone,' says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal maintains a Buy rating on Amyris with an $11 price target after the company entered into a long-term agreement with Xinfu for an upfront payment of $50M and an additional long-term annual share upside based on an existing nutritional product royalty arrangement. Amyris is capitalizing on its relationship with Xinfu to monetize a portion of the long-term royalty opportunity upfront, which should lower quarterly volatility from this "high-margin" revenue stream while continuing to benefit from future royalty payments, Dayal tells investors in a research note. He thinks today's news should be viewed as a "timely delivery of a significant near-term milestone by the management team."
02/05/19
HCWC
02/05/19
NO CHANGE
Target $11
HCWC
Buy
H.C. Wainwright reiterates $11 target on Amyris after $255M cannabinoid deal
Amyris this morning announced a $255M collaboration agreement, its largest yet, with an unnamed partner, for cannabinoid development and licensing, H.C. Wainwright analyst Amit Dayal tells investors in a research note. The analyst reiterates a Buy rating on the shares with an $11 price target. The stock in morning trading is up 42%, or $1.33, to $4.49. Dayal believes the agreement calls for several molecules that will be targeting multiple products and end markets, with the first commercial production taking place in 18-24 months. He thinks the early applications are targeting opportunities in the skin care and beverage markets. Further, with an executed binding term sheet in place leading to the announcement, Dayal sees a "high probability" of the deal closing within the expected timeline. And since the non-psychoactive cannabidiol based molecules developed using Amyris' fermentation technology are likely to bypass the psychoactive tetrahydrocannabinol molecule pathway, the regulatory approval process "should not run afoul of the federal THC related restrictions," the analyst writes. He views today's announcement as an "important signal about the scalability" of Amyris' technology platform to enter large new markets very quickly. The analyst also believes the development timeline is "realistic given that product development has been accelerating at the company."

TODAY'S FREE FLY STORIES

TMUS

T-Mobile

$75.47

-0.07 (-0.09%)

, S

Sprint

$6.83

-0.03 (-0.44%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Periodicals
Gasparino: T-Mobile, Sprint think 'today could be the day' for DOJ announcement »

FBN's Charles…

TMUS

T-Mobile

$75.47

-0.07 (-0.09%)

S

Sprint

$6.83

-0.03 (-0.44%)

DISH

Dish

$38.13

-0.46 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPDF

PPDAI Group

$4.00

-0.32 (-7.41%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
PPDAI Group falls -7.4% »

PPDAI Group is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$66.87

-11.545 (-14.72%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
AbbVie falls -14.8% »

AbbVie is down -14.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

FTSI

FTS International

$5.30

-0.47 (-8.15%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
FTS International falls -7.5% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USNA

Usana

$79.01

6.605 (9.12%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
Usana rises 9.4% »

Usana is up 9.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$165.05

35.4 (27.30%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
Allergan rises 27.4% »

Allergan is up 27.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYX

Pyxus

$17.20

3.78 (28.17%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
Pyxus rises 27.8% »

Pyxus is up 27.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$9.80

0.47 (5.04%)

09:58
06/25/19
06/25
09:58
06/25/19
09:58
Recommendations
Dova Pharmaceuticals analyst commentary  »

H.C. Wainwright says Dova…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

AGN

Allergan

$165.16

35.51 (27.39%)

, MNK

Mallinckrodt

$8.48

0.06 (0.71%)

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Options
Early notable gainers among liquid option names on June 25th »

Notable gainers among…

AGN

Allergan

$165.16

35.51 (27.39%)

MNK

Mallinckrodt

$8.48

0.06 (0.71%)

MYL

Mylan

$18.16

0.2 (1.11%)

BIIB

Biogen

$239.70

3.81 (1.62%)

CAG

Conagra Brands

$28.53

0.42 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 23

    Jul

FNMA

Fannie Mae

$0.00

(0.00%)

, FMCC

Freddie Mac

$0.00

(0.00%)

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

FNMA

Fannie Mae

$0.00

(0.00%)

FMCC

Freddie Mac

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Conference/Events
House Committee on Natural Resources to hold a hearing »

The Subcommittee on…

AGN

Allergan

$165.75

36.1 (27.84%)

09:52
06/25/19
06/25
09:52
06/25/19
09:52
Options
Call flow in Allergan last week suggests potential deal leakage »

Call flow in Allergan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHG

InterContinental

$67.24

-0.1 (-0.15%)

, SCHYY

Sands China

$0.00

(0.00%)

09:49
06/25/19
06/25
09:49
06/25/19
09:49
Hot Stocks
InterContinental, Sands China extend partnership »

InterContinental (IHG)…

IHG

InterContinental

$67.24

-0.1 (-0.15%)

SCHYY

Sands China

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AMZN

Amazon.com

$1,914.14

0.71 (0.04%)

, ROKU

Roku

$98.12

-1.86 (-1.86%)

09:49
06/25/19
06/25
09:49
06/25/19
09:49
Periodicals
Amazon introducing three new smart televisions, Ars Technica reports »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,914.14

0.71 (0.04%)

ROKU

Roku

$98.12

-1.86 (-1.86%)

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

GTES

Gates Industrial

$12.72

1.905 (17.61%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47
Hot Stocks
Gates Industrial rises 19.1% »

Gates Industrial is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYX

Pyxus

$16.91

3.49 (26.01%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47
Hot Stocks
Pyxus rises 26.5% »

Pyxus is up 26.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$167.63

37.98 (29.29%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47
Hot Stocks
Allergan rises 29.4% »

Allergan is up 29.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/25/19
06/25
09:45
06/25/19
09:45
General news
New Home Sales to be reported at 10:00 »

May New Home Sales will…

09:45
06/25/19
06/25
09:45
06/25/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

June Richmond Fed…

09:45
06/25/19
06/25
09:45
06/25/19
09:45
General news
Consumer Confidence to be reported at 10:00 »

June Consumer Confidence…

HPE

HP Enterprise

$15.00

(0.00%)

09:41
06/25/19
06/25
09:41
06/25/19
09:41
Conference/Events
HP Enterprise management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

HRL

Hormel Foods

$42.15

(0.00%)

, AGN

Allergan

$129.65

(0.00%)

09:40
06/25/19
06/25
09:40
06/25/19
09:40
Options
Unusually active option classes on open June 25th »

Unusual total active…

HRL

Hormel Foods

$42.15

(0.00%)

AGN

Allergan

$129.65

(0.00%)

BHC

Bausch Health

$23.76

(0.00%)

GRUB

GrubHub

$72.05

(0.00%)

PM

Philip Morris

$77.83

(0.00%)

NOV

National Oilwell

$21.28

(0.00%)

RIOT

Riot Blockchain

$3.05

(0.00%)

FDX

FedEx

$160.88

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$12.73

(0.00%)

ATVI

Activision Blizzard

$47.16

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 30

    Jul

  • 30

    Jul

  • 31

    Jul

  • 27

    Aug

  • 13

    Nov

09:40
06/25/19
06/25
09:40
06/25/19
09:40
General news
U.S. new home sales preview: »

U.S. new home sales…

09:40
06/25/19
06/25
09:40
06/25/19
09:40
General news
U.S. consumer confidence preview: »

U.S. consumer confidence…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.